DeepMirror AI

DeepMirror

This company develops an artificial intelligence platform for medicinal chemists at biotechnology and pharmaceutical firms to design and optimise drug molecules.

AI-enabled drug design

This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.

Deep Origin

This company provides a computational drug discovery platform for biopharmaceutical researchers to simulate molecular properties and accelerate therapeutic development.

Valence Discovery

This company provides a machine learning platform for molecular design and lead optimisation to pharmaceutical and biotechnology firms.

Deep MedChem

This company develops artificial intelligence software for virtual screening and molecular discovery for pharmaceutical, biotechnology and academic drug discovery teams.

Anagenex

This company develops a machine learning and biochemistry platform to identify and optimise small molecule drug candidates for pharmaceutical and biotechnology organisations.

Avicenna Biosciences

The company develops a machine learning platform to optimise small molecule drug discovery and lead-to-candidate processes for biotechnology and pharmaceutical organisations.

Deepcure

This company develops small molecule therapies for pharmaceutical organisations to treat inflammatory and autoimmune diseases using artificial intelligence and automated discovery tools.